Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
about
Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
P2860
Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Gambogic acid sensitizes gemci ...... e reductase subunit-M2 (RRM2).
@en
type
label
Gambogic acid sensitizes gemci ...... e reductase subunit-M2 (RRM2).
@en
prefLabel
Gambogic acid sensitizes gemci ...... e reductase subunit-M2 (RRM2).
@en
P2093
P2860
P1476
Gambogic acid sensitizes gemci ...... e reductase subunit-M2 (RRM2).
@en
P2093
Guanggai Xia
Hongcheng Wang
Qingcai Meng
Xinyu Huang
Xiuyan Huang
Ziliang Song
P2860
P2888
P356
10.1186/S13046-017-0579-0
P577
2017-08-10T00:00:00Z
P6179
1091144588